IMMUNE GLOBULIN INTRAVENOUS (HUMAN)

IMMUNE GLOBULIN INTRAVENOUS (HUMAN) was reported 6472 times

IMMUNE GLOBULIN INTRAVENOUS (HUMAN) is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTI-HUMAN ANTIBODY TEST 6 0.2222
1 FEBRILE NONHAEMOLYTIC TRANSFUSION REACTION 32 0.1702
2 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 34 0.1012
3 ANTI A ANTIBODY POSITIVE 5 0.0909
4 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 35 0.0763
5 BODY HEIGHT BELOW NORMAL 36 0.0560
6 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 24 0.0531
7 CORONARY ARTERY ANEURYSM 11 0.0468
8 SHORT STATURE 11 0.0420
9 SMOOTH MUSCLE CELL NEOPLASM 17 0.0407
10 TRANSFUSION-RELATED ACUTE LUNG INJURY 12 0.0390
11 BONE DENSITY INCREASED 15 0.0376
12 ALLERGIC TRANSFUSION REACTION 5 0.0331
13 JOINT DESTRUCTION 46 0.0296
14 MENINGITIS ASEPTIC 114 0.0254
15 HEPATITIS A ANTIBODY POSITIVE 5 0.0253
16 BLOOD IMMUNOGLOBULIN G ABNORMAL 4 0.0240
17 VASCULAR ACCESS SITE COMPLICATION 6 0.0238
18 GINGIVAL OEDEMA 4 0.0227
19 IMMUNODEFICIENCY COMMON VARIABLE 10 0.0205
20 ANTIBODY TEST POSITIVE 34 0.0205
21 PEPTIC ULCER PERFORATION 6 0.0199
22 STIFF PERSON SYNDROME 6 0.0173
23 ANGINA BULLOSA HAEMORRHAGICA 4 0.0172
24 PRODUCT CLOSURE ISSUE 9 0.0162
25 HEPATITIS B CORE ANTIBODY POSITIVE 6 0.0159
26 LYMPHADENITIS 38 0.0157
27 BONE MARROW RETICULIN FIBROSIS 4 0.0155
28 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 35 0.0152
29 TRANSFUSION REACTION 13 0.0148
30 DRUG SPECIFIC ANTIBODY 20 0.0146
31 IMMUNOGLOBULINS DECREASED 20 0.0146
32 JUVENILE IDIOPATHIC ARTHRITIS 35 0.0143
33 ANKLE ARTHROPLASTY 5 0.0138
34 ANAEMIA HAEMOLYTIC AUTOIMMUNE 11 0.0133
35 HISTIOCYTOSIS HAEMATOPHAGIC 39 0.0131
36 ADRENAL SUPPRESSION 11 0.0130
37 HYPERGAMMAGLOBULINAEMIA 6 0.0124
38 POLYARTHRITIS 57 0.0108
39 IDIOPATHIC THROMBOCYTOPENIC PURPURA 17 0.0108
40 BLOOD IMMUNOGLOBULIN G DECREASED 24 0.0097
41 COVID-19 IMMUNISATION 8 0.0096
42 PERIORAL DERMATITIS 6 0.0094
43 HAEMOLYSIS 73 0.0094
44 MAST CELL ACTIVATION SYNDROME 13 0.0093
45 BLOOD IMMUNOGLOBULIN A DECREASED 6 0.0092
46 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 13 0.0090
47 INCORRECT DRUG ADMINISTRATION RATE 38 0.0089
48 BODY MASS INDEX DECREASED 4 0.0086
49 ENCEPHALITIS HERPES 4 0.0081
50 MIGRAINE WITH AURA 22 0.0081
51 MYASTHENIC SYNDROME 6 0.0078
52 MUSCLE SWELLING 7 0.0076
53 SUPERINFECTION BACTERIAL 6 0.0076
54 VULVAL DISORDER 5 0.0076
55 T-LYMPHOCYTE COUNT DECREASED 5 0.0073
56 INFUSION SITE RASH 10 0.0073
57 DEVICE INFUSION ISSUE 18 0.0073
58 WHEELCHAIR USER 32 0.0072
59 BONE MARROW DEPRESSION 7 0.0072
60 INFUSION SITE BRUISING 15 0.0069
61 ANAPHYLACTOID REACTION 28 0.0068
62 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 8 0.0064
63 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 5 0.0064
64 PLACENTAL INSUFFICIENCY 5 0.0062
65 LIVEDO RETICULARIS 13 0.0062
66 CATHETER RELATED COMPLICATION 7 0.0062
67 C-REACTIVE PROTEIN DECREASED 4 0.0061
68 ASPERGILLOSIS 8 0.0061
69 CSF PROTEIN INCREASED 5 0.0060
70 INFUSION RELATED REACTION 397 0.0060
71 BLOOD IMMUNOGLOBULIN M DECREASED 6 0.0060
72 ADRENAL INSUFFICIENCY 71 0.0058
73 INFUSION SITE DISCOMFORT 6 0.0058
74 HIRSUTISM 7 0.0053
75 INFUSION SITE SWELLING 33 0.0052
76 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 7 0.0052
77 HYPOGAMMAGLOBULINAEMIA 34 0.0052
78 MENINGITIS 34 0.0051
79 INTRA-UTERINE DEATH 8 0.0050
80 CATHETER RELATED INFECTION 5 0.0049
81 HAEMOLYTIC ANAEMIA 44 0.0049
82 EPSTEIN-BARR VIRUS INFECTION 30 0.0048
83 ENTEROBACTER INFECTION 8 0.0048
84 DRUG TOLERANCE 24 0.0047
85 PNEUMONIA CYTOMEGALOVIRAL 9 0.0046
86 B-LYMPHOCYTE COUNT DECREASED 6 0.0044
87 DERMATOMYOSITIS 11 0.0043
88 RHEUMATOID FACTOR POSITIVE 25 0.0043
89 FACIAL ASYMMETRY 4 0.0042
90 INFUSION SITE PRURITUS 13 0.0041
91 BLOOD IMMUNOGLOBULIN G INCREASED 5 0.0041
92 MYASTHENIA GRAVIS CRISIS 6 0.0040
93 NO THERAPEUTIC RESPONSE 49 0.0040
94 INFUSION SITE REACTION 12 0.0040
95 OBESITY 64 0.0040
96 ORAL MUCOSAL EXFOLIATION 6 0.0040
97 GINGIVAL HYPERTROPHY 6 0.0040
98 DEMYELINATING POLYNEUROPATHY 4 0.0039
99 IATROGENIC INJURY 5 0.0039
100 NEONATAL DISORDER 6 0.0038
101 HYPOVITAMINOSIS 5 0.0038
102 VARICELLA 9 0.0038
103 HEPATITIS C 45 0.0037
104 ANTINUCLEAR ANTIBODY POSITIVE 12 0.0037
105 DEATH NEONATAL 5 0.0036
106 IMMUNODEFICIENCY 53 0.0036
107 INJECTION SITE OEDEMA 6 0.0035
108 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 25 0.0035
109 INFUSION SITE PAIN 44 0.0034
110 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 6 0.0034
111 CYTOMEGALOVIRUS VIRAEMIA 15 0.0034
112 RED BLOOD CELL SEDIMENTATION RATE INCREASED 37 0.0033
113 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 17 0.0033
114 GRAFT VERSUS HOST DISEASE 24 0.0033
115 DILATATION VENTRICULAR 7 0.0033
116 GASTROENTERITIS VIRAL 60 0.0033
117 INFUSION SITE ERYTHEMA 28 0.0033
118 TRANSPLANT FAILURE 8 0.0033
119 HEPATITIS B REACTIVATION 10 0.0031
120 PNEUMOCYSTIS JIROVECI PNEUMONIA 7 0.0031
121 HAEMOLYTIC URAEMIC SYNDROME 7 0.0030
122 PNEUMONIA ASPIRATION 75 0.0030
123 CENTRAL VENOUS CATHETERISATION 9 0.0030
124 BLOOD AMYLASE INCREASED 5 0.0029
125 POOR VENOUS ACCESS 30 0.0029
126 DERMATITIS EXFOLIATIVE 14 0.0028
127 CHRONIC LYMPHOCYTIC LEUKAEMIA 13 0.0027
128 INFUSION SITE HAEMORRHAGE 9 0.0027
129 MYASTHENIA GRAVIS 22 0.0027
130 CEREBROSPINAL FLUID LEAKAGE 5 0.0027
131 RESPIRATORY RATE INCREASED 24 0.0027
132 HYPOCALCAEMIA 51 0.0027
133 CREPITATIONS 8 0.0027
134 SYNOVITIS 48 0.0027
135 PROTEIN TOTAL INCREASED 7 0.0026
136 JOINT EFFUSION 18 0.0026
137 RALES 15 0.0026
138 TACHYPNOEA 35 0.0026
139 THROMBOPHLEBITIS 9 0.0026
140 INSURANCE ISSUE 39 0.0025
141 FOOT DEFORMITY 28 0.0025
142 SERUM SICKNESS 7 0.0025
143 ANTIPHOSPHOLIPID SYNDROME 4 0.0025
144 HAEMORRHAGE INTRACRANIAL 37 0.0025
145 VENOUS THROMBOSIS LIMB 5 0.0024
146 DISSEMINATED INTRAVASCULAR COAGULATION 34 0.0024
147 ADENOVIRUS INFECTION 7 0.0024
148 CHRONIC SINUSITIS 9 0.0024
149 LYMPHOPROLIFERATIVE DISORDER 7 0.0024
150 WOUND DEHISCENCE 8 0.0024
151 MULTIPLE MYELOMA 11 0.0024
152 CHILLS 274 0.0023
153 AUTOIMMUNE HAEMOLYTIC ANAEMIA 8 0.0023
154 HEPATIC FIBROSIS 8 0.0023
155 VARICES OESOPHAGEAL 7 0.0023
156 THROMBOPHLEBITIS SUPERFICIAL 7 0.0023
157 INFUSION SITE EXTRAVASATION 14 0.0022
158 AREFLEXIA 6 0.0022
159 PRODUCT CONTAMINATION 8 0.0022
160 INFECTIOUS MONONUCLEOSIS 5 0.0022
161 MULTI-ORGAN FAILURE 38 0.0022
162 STREPTOCOCCAL INFECTION 12 0.0022
163 ACUTE PULMONARY OEDEMA 12 0.0021
164 HAEMATOLOGICAL MALIGNANCY 6 0.0021
165 PREMATURE RUPTURE OF MEMBRANES 5 0.0021
166 EARLY SATIETY 4 0.0021
167 DRUG DELIVERY SYSTEM ISSUE 4 0.0020
168 BODY TEMPERATURE INCREASED 41 0.0020
169 SEPTIC SHOCK 87 0.0020
170 NODULE 26 0.0020
171 PLATELET DISORDER 5 0.0020
172 KLEBSIELLA INFECTION 10 0.0020
173 BODY TEMPERATURE FLUCTUATION 4 0.0019
174 EYE CONTUSION 4 0.0019
175 BONE DENSITY ABNORMAL 7 0.0019
176 GUILLAIN-BARRE SYNDROME 9 0.0019
177 SINUSITIS 190 0.0019
178 LIVER ABSCESS 6 0.0018
179 CEREBELLAR SYNDROME 4 0.0018
180 HEPATITIS B 11 0.0018
181 OTITIS MEDIA 6 0.0018
182 RHINOVIRUS INFECTION 7 0.0018
183 PREMATURE LABOUR 10 0.0018
184 PSEUDOMONAS INFECTION 15 0.0017
185 TRANSPLANT REJECTION 14 0.0017
186 DRUG EXPOSURE DURING PREGNANCY 59 0.0017
187 COMA 81 0.0017
188 ASPERGILLUS INFECTION 11 0.0017
189 PULMONARY FIBROSIS 32 0.0017
190 ANAPHYLACTIC REACTION 91 0.0016
191 ESCHERICHIA URINARY TRACT INFECTION 7 0.0016
192 BRONCHITIS CHRONIC 4 0.0016
193 BRONCHIECTASIS 11 0.0016
194 PROTEIN TOTAL DECREASED 6 0.0016
195 THERAPEUTIC PRODUCT EFFECT DECREASED 71 0.0016
196 PARANASAL SINUS DISCOMFORT 6 0.0016
197 DERMATITIS CONTACT 18 0.0016
198 PNEUMONIA VIRAL 5 0.0016
199 HERPES VIRUS INFECTION 9 0.0016
200 C-REACTIVE PROTEIN ABNORMAL 10 0.0016
201 CUSHINGOID 5 0.0016
202 BRONCHOPULMONARY ASPERGILLOSIS 12 0.0015
203 LYMPHOCYTE COUNT INCREASED 5 0.0015
204 ACUTE GRAFT VERSUS HOST DISEASE 7 0.0015
205 NYSTAGMUS 8 0.0015
206 CYTOMEGALOVIRUS INFECTION 25 0.0015
207 CANDIDIASIS 6 0.0015
208 TRIGEMINAL NEURALGIA 6 0.0015
209 BK VIRUS INFECTION 5 0.0015
210 SHOCK 34 0.0015
211 BRONCHOSPASM 21 0.0015
212 BACTERIAL INFECTION 27 0.0014
213 THROMBOTIC MICROANGIOPATHY 14 0.0014
214 EAR INFECTION 38 0.0014
215 ENDOTRACHEAL INTUBATION 4 0.0014
216 MIGRAINE 136 0.0014
217 FOOT OPERATION 7 0.0014
218 ACUTE RESPIRATORY DISTRESS SYNDROME 25 0.0014
219 INCREASED TENDENCY TO BRUISE 13 0.0014
220 INFECTION 203 0.0014
221 HEREDITARY ANGIOEDEMA 15 0.0014
222 PLEURAL EFFUSION 85 0.0014
223 VISUAL DISTURBANCE 8 0.0014
224 BLOOD LACTATE DEHYDROGENASE INCREASED 22 0.0014
225 HYPOKALAEMIA 64 0.0014
226 PARAESTHESIA ORAL 20 0.0014
227 INTENTIONAL PRODUCT USE ISSUE 121 0.0014
228 C-REACTIVE PROTEIN INCREASED 50 0.0014
229 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4 0.0014
230 LIMB DISCOMFORT 42 0.0014
231 OXYGEN SATURATION DECREASED 76 0.0014
232 LEUKOENCEPHALOPATHY 5 0.0013
233 SKIN INFECTION 15 0.0013
234 AUTOIMMUNE DISORDER 13 0.0013
235 AUTOIMMUNE THYROIDITIS 5 0.0013
236 JOINT INJURY 28 0.0013
237 HAEMODIALYSIS 11 0.0013
238 INABILITY TO AFFORD MEDICATION 13 0.0013
239 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 5 0.0013
240 THERAPY NON-RESPONDER 58 0.0013
241 SWELLING OF EYELID 8 0.0013
242 RENAL FAILURE ACUTE 54 0.0013
243 PNEUMONIA FUNGAL 5 0.0013
244 SINUS DISORDER 25 0.0013
245 PRODUCT SUPPLY ISSUE 9 0.0013
246 APHAGIA 6 0.0012
247 LYMPHADENOPATHY 44 0.0012
248 ENTEROCOCCAL INFECTION 6 0.0012
249 CYSTITIS HAEMORRHAGIC 5 0.0012
250 RESPIRATORY DISORDER 37 0.0012
251 BACTERIAL SEPSIS 4 0.0012
252 PLATELET COUNT INCREASED 16 0.0012
253 PRODUCT PREPARATION ISSUE 8 0.0012
254 BLOOD PRESSURE DIASTOLIC DECREASED 9 0.0012
255 BLOOD PRESSURE INCREASED 185 0.0012
256 SPLENOMEGALY 14 0.0012
257 BLOOD UREA INCREASED 20 0.0012
258 TACHYCARDIA 106 0.0012
259 CEREBRAL HAEMATOMA 4 0.0012
260 FEELING COLD 33 0.0012
261 TOXIC EPIDERMAL NECROLYSIS 18 0.0012
262 HYPERTHERMIA 9 0.0012
263 NEUTROPENIA 160 0.0012
264 POOR PERIPHERAL CIRCULATION 5 0.0012
265 PHOTOPHOBIA 22 0.0012
266 LIVER FUNCTION TEST ABNORMAL 34 0.0012
267 UPPER RESPIRATORY TRACT INFECTION 54 0.0012
268 PRODUCT TEMPERATURE EXCURSION ISSUE 6 0.0012
269 FOOD ALLERGY 9 0.0012
270 PLATELET COUNT ABNORMAL 7 0.0012
271 PULMONARY HYPERTENSION 24 0.0012
272 RESPIRATORY TRACT INFECTION 30 0.0012
273 PULMONARY HAEMORRHAGE 9 0.0011
274 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
275 RESPIRATORY SYNCYTIAL VIRUS INFECTION 10 0.0011
276 MULTIPLE ALLERGIES 9 0.0011
277 POST PROCEDURAL COMPLICATION 22 0.0011
278 PYREXIA 394 0.0011
279 PULMONARY CONGESTION 15 0.0011
280 TRICUSPID VALVE INCOMPETENCE 9 0.0011
281 SEASONAL ALLERGY 16 0.0011
282 PURPURA 10 0.0011
283 THERMAL BURN 8 0.0011
284 FIBRIN D DIMER INCREASED 4 0.0011
285 PHARYNGEAL SWELLING 11 0.0011
286 CONJUNCTIVAL HYPERAEMIA 4 0.0011
287 BONE DENSITY DECREASED 35 0.0011
288 RHINITIS 9 0.0011
289 BLOOD BILIRUBIN INCREASED 30 0.0011
290 CHEILITIS 6 0.0011
291 BRAIN OEDEMA 14 0.0011
292 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 19 0.0011
293 CEREBRAL INFARCTION 27 0.0011
294 VASCULAR DEVICE INFECTION 5 0.0011
295 PULMONARY THROMBOSIS 12 0.0011
296 DISEASE COMPLICATION 5 0.0011
297 ACUTE MYELOID LEUKAEMIA 17 0.0011
298 HAEMOGLOBIN ABNORMAL 7 0.0011
299 AMYLASE INCREASED 4 0.0011
300 BLOOD PRESSURE DIASTOLIC INCREASED 5 0.0011
301 LOCALISED OEDEMA 5 0.0011
302 HYPOMAGNESAEMIA 15 0.0011
303 DRUG SPECIFIC ANTIBODY PRESENT 7 0.0011
304 FLANK PAIN 10 0.0011
305 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 51 0.0011
306 QUALITY OF LIFE DECREASED 14 0.0010
307 CONCUSSION 8 0.0010
308 CAESAREAN SECTION 12 0.0010
309 NEPHROTIC SYNDROME 7 0.0010
310 URTICARIA 171 0.0010
311 HEPATOMEGALY 10 0.0010
312 RESPIRATORY FAILURE 74 0.0010
313 SYSTEMIC LUPUS ERYTHEMATOSUS 36 0.0010
314 BREATH SOUNDS ABNORMAL 5 0.0010
315 STAPHYLOCOCCAL SEPSIS 5 0.0010
316 VENOOCCLUSIVE LIVER DISEASE 5 0.0010
317 SKIN LACERATION 11 0.0010
318 BACTERAEMIA 12 0.0010
319 PLEURISY 6 0.0010
320 ORGANISING PNEUMONIA 5 0.0010
321 GASTROOESOPHAGEAL REFLUX DISEASE 81 0.0010
322 CYSTITIS 32 0.0010
323 SEPSIS 112 0.0010
324 GASTROINTESTINAL INFECTION 9 0.0010
325 CEREBRAL ATROPHY 4 0.0010
326 PROTHROMBIN TIME PROLONGED 6 0.0010
327 PROTEIN URINE PRESENT 5 0.0010
328 VEIN DISORDER 5 0.0010
329 DRUG INTOLERANCE 96 0.0010
330 PALLOR 27 0.0010
331 CORONARY ARTERY DISEASE 30 0.0010
332 PRODUCT SOLUBILITY ABNORMAL 5 0.0010
333 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
334 DIALYSIS 14 0.0010
335 BRONCHITIS 73 0.0010
336 MALNUTRITION 11 0.0010
337 HEPATIC ENZYME INCREASED 67 0.0010
338 PHLEBITIS 5 0.0010
339 EXTRAVASATION 4 0.0010
340 HEADACHE 609 0.0010
341 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 8 0.0010
342 MYELODYSPLASTIC SYNDROME 14 0.0010
343 PRODUCT AVAILABILITY ISSUE 22 0.0010
344 ARTHRITIS 76 0.0010
345 EMBOLISM 8 0.0010
346 VIRAL INFECTION 32 0.0010
347 MOBILITY DECREASED 69 0.0010
348 LIQUID PRODUCT PHYSICAL ISSUE 7 0.0010
349 HAEMATOCRIT DECREASED 19 0.0010
350 PULMONARY EMBOLISM 91 0.0010
351 CHEST DISCOMFORT 98 0.0010
352 CYANOSIS 15 0.0010
353 SPUTUM DISCOLOURED 9 0.0009
354 GASTRIC ULCER 18 0.0009
355 VASCULITIS 11 0.0009
356 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 9 0.0009
357 SPINAL PAIN 11 0.0009
358 ENCEPHALOPATHY 23 0.0009
359 ARTHROPATHY 52 0.0009
360 BONE MARROW FAILURE 19 0.0009
361 FOOD POISONING 5 0.0009
362 GINGIVITIS 5 0.0009
363 HERPES ZOSTER 53 0.0009
364 TROPONIN INCREASED 7 0.0009
365 MULTIPLE ORGAN DYSFUNCTION SYNDROME 26 0.0009
366 URINE OUTPUT DECREASED 8 0.0009
367 BODY TEMPERATURE DECREASED 9 0.0009
368 MATERNAL DRUGS AFFECTING FOETUS 7 0.0009
369 WHITE BLOOD CELL COUNT INCREASED 35 0.0009
370 HEPATIC FUNCTION ABNORMAL 34 0.0009
371 IMMUNE SYSTEM DISORDER 12 0.0009
372 WALKING AID USER 6 0.0009
373 STAPHYLOCOCCAL INFECTION 30 0.0009
374 BLOOD PRESSURE ABNORMAL 18 0.0009
375 CATHETERISATION CARDIAC 4 0.0009
376 HYPOALBUMINAEMIA 7 0.0009
377 CARDIOMEGALY 11 0.0009
378 FLUID OVERLOAD 13 0.0009
379 BRAIN FOG 14 0.0009
380 ANAPHYLACTIC SHOCK 23 0.0009
381 PULMONARY ALVEOLAR HAEMORRHAGE 5 0.0009
382 PLATELET COUNT DECREASED 95 0.0009
383 POSTOPERATIVE WOUND INFECTION 6 0.0009
384 CANDIDA INFECTION 15 0.0009
385 BLOOD PRESSURE DECREASED 59 0.0009
386 THROAT TIGHTNESS 24 0.0009
387 HYPOXIA 31 0.0009
388 PERONEAL NERVE PALSY 5 0.0009
389 ACUTE HEPATIC FAILURE 12 0.0009
390 RIB FRACTURE 18 0.0009
391 FUNGAL INFECTION 29 0.0009
392 HYPERBILIRUBINAEMIA 9 0.0009
393 THROMBOCYTOPENIA 97 0.0009
394 TENDERNESS 9 0.0009
395 PRODUCT DISTRIBUTION ISSUE 8 0.0009
396 POST PROCEDURAL INFECTION 7 0.0009
397 SKIN WARM 5 0.0009
398 CONTRAINDICATED PRODUCT ADMINISTERED 26 0.0009
399 PRESCRIBED UNDERDOSE 17 0.0009
400 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
401 UNDERDOSE 62 0.0008
402 RENAL PAIN 9 0.0008
403 SINUS HEADACHE 5 0.0008
404 ILLNESS 86 0.0008
405 IMPAIRED QUALITY OF LIFE 12 0.0008
406 PHARYNGITIS STREPTOCOCCAL 9 0.0008
407 GANGRENE 5 0.0008
408 TONGUE DISORDER 6 0.0008
409 FOETAL GROWTH RESTRICTION 5 0.0008
410 PNEUMOTHORAX 13 0.0008
411 PRODUCT CONTAINER ISSUE 7 0.0008
412 THERAPY CHANGE 8 0.0008
413 BLOOD MAGNESIUM DECREASED 7 0.0008
414 OLIGURIA 5 0.0008
415 TOOTH EXTRACTION 10 0.0008
416 TRANSIENT ISCHAEMIC ATTACK 27 0.0008
417 HYPOAESTHESIA ORAL 12 0.0008
418 CELLULITIS 40 0.0008
419 IMMUNOSUPPRESSION 7 0.0008
420 OEDEMA 43 0.0008
421 FOOT FRACTURE 15 0.0008
422 PNEUMONIA 256 0.0008
423 MASS 11 0.0008
424 MYOCARDITIS 9 0.0008
425 BLOOD TEST ABNORMAL 11 0.0008
426 COAGULOPATHY 13 0.0008
427 ACUTE MYOCARDIAL INFARCTION 23 0.0008
428 DEVICE RELATED INFECTION 12 0.0008
429 CLOSTRIDIUM DIFFICILE INFECTION 17 0.0008
430 DRUG RESISTANCE 20 0.0008
431 WHEEZING 46 0.0008
432 FOETAL DEATH 4 0.0008
433 DEEP VEIN THROMBOSIS 50 0.0008
434 LIVER DISORDER 34 0.0008
435 PETECHIAE 8 0.0008
436 APLASTIC ANAEMIA 4 0.0008
437 KIDNEY INFECTION 15 0.0008
438 PNEUMONIA BACTERIAL 7 0.0008
439 HAND DEFORMITY 10 0.0008
440 FURUNCLE 6 0.0008
441 MUSCULOSKELETAL DISCOMFORT 13 0.0008
442 ARTERIOSCLEROSIS CORONARY ARTERY 5 0.0008
443 LEUKAEMIA 7 0.0007
444 MUSCLE DISORDER 6 0.0007
445 WRONG PRODUCT ADMINISTERED 5 0.0007
446 SPINAL DISORDER 7 0.0007
447 BLOOD URINE PRESENT 14 0.0007
448 ASPARTATE AMINOTRANSFERASE INCREASED 39 0.0007
449 IMPAIRED GASTRIC EMPTYING 10 0.0007
450 PHARMACEUTICAL PRODUCT COMPLAINT 19 0.0007
451 ESCHERICHIA INFECTION 6 0.0007
452 ECCHYMOSIS 5 0.0007
453 PERIPHERAL COLDNESS 10 0.0007
454 HYPERTENSION 154 0.0007
455 TOOTH FRACTURE 8 0.0007
456 LOSS OF CONSCIOUSNESS 92 0.0007
457 RENAL TUBULAR NECROSIS 7 0.0007
458 FACE OEDEMA 12 0.0007
459 ILL-DEFINED DISORDER 43 0.0007
460 GRANULOCYTOPENIA 4 0.0007
461 NEPHROLITHIASIS 32 0.0007
462 HEPATIC FAILURE 21 0.0007
463 PERICARDIAL EFFUSION 16 0.0007
464 LIP SWELLING 23 0.0007
465 COVID-19 121 0.0007
466 NEUTROPHIL COUNT INCREASED 7 0.0007
467 TOOTH INFECTION 9 0.0007
468 EAR DISCOMFORT 7 0.0007
469 URINARY TRACT INFECTION 116 0.0007
470 STEVENS-JOHNSON SYNDROME 15 0.0007
471 POLYNEUROPATHY 8 0.0007
472 BLOOD PRESSURE SYSTOLIC INCREASED 13 0.0007
473 CONVULSION 38 0.0007
474 POOR QUALITY PRODUCT ADMINISTERED 7 0.0007
475 APHASIA 20 0.0007
476 GINGIVAL BLEEDING 9 0.0007
477 FIBROMYALGIA 16 0.0007
478 HYPOTENSION 132 0.0007
479 INFLUENZA 73 0.0007
480 BACK PAIN 152 0.0007
481 NEEDLE ISSUE 19 0.0007
482 HAEMOGLOBIN DECREASED 67 0.0007
483 VOMITING 306 0.0007
484 RENAL FAILURE CHRONIC 5 0.0006
485 IRON DEFICIENCY ANAEMIA 6 0.0006
486 CHOLANGITIS 4 0.0006
487 ERYTHEMA MULTIFORME 6 0.0006
488 SCAR 11 0.0006
489 APNOEA 5 0.0006
490 ABORTION INDUCED 6 0.0006
491 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
492 HEART RATE INCREASED 63 0.0006
493 PARALYSIS 9 0.0006
494 PERITONITIS 13 0.0006
495 RASH ERYTHEMATOUS 30 0.0006
496 NECK PAIN 35 0.0006
497 BLOOD CALCIUM DECREASED 7 0.0006
498 ATELECTASIS 6 0.0006
499 SKIN LESION 17 0.0006
500 INFLUENZA LIKE ILLNESS 51 0.0006
501 ASTHMA 70 0.0006
502 GASTROENTERITIS 9 0.0006
503 ISCHAEMIC STROKE 11 0.0006
504 RESPIRATORY DISTRESS 17 0.0006
505 SHOCK HAEMORRHAGIC 5 0.0006
506 DECUBITUS ULCER 5 0.0006
507 POLYURIA 5 0.0006
508 RASH PRURITIC 33 0.0006
509 PANCYTOPENIA 34 0.0006
510 ORAL CANDIDIASIS 8 0.0006
511 DEPRESSED LEVEL OF CONSCIOUSNESS 24 0.0006
512 BLISTER 34 0.0006
513 NAUSEA 479 0.0006
514 PULMONARY MASS 9 0.0006
515 ACUTE CORONARY SYNDROME 5 0.0006
516 TREMOR 100 0.0006
517 HEMIPLEGIA 5 0.0006
518 ABORTION SPONTANEOUS 24 0.0006
519 PSORIASIS 78 0.0006
520 BREAST MASS 4 0.0006
521 RED BLOOD CELL COUNT DECREASED 17 0.0006
522 CONJUNCTIVITIS 11 0.0006
523 COVID-19 PNEUMONIA 7 0.0006
524 BLOOD IRON DECREASED 7 0.0006
525 LIMB INJURY 16 0.0006
526 ABNORMAL LOSS OF WEIGHT 4 0.0006
527 ALANINE AMINOTRANSFERASE INCREASED 36 0.0006
528 DYSARTHRIA 22 0.0006
529 EYE MOVEMENT DISORDER 4 0.0006
530 TENDONITIS 9 0.0006
531 PULMONARY OEDEMA 26 0.0006
532 RENAL DISORDER 27 0.0006
533 DYSPNOEA 328 0.0006
534 MYOPATHY 5 0.0006
535 ENCEPHALITIS 4 0.0006
536 RENAL IMPAIRMENT 48 0.0006
537 GROIN PAIN 5 0.0006
538 PRODUCTIVE COUGH 27 0.0006
539 GENERALISED OEDEMA 7 0.0006
540 CYST 7 0.0006
541 BREAST PAIN 6 0.0006
542 FACIAL PAIN 5 0.0006
543 THERAPY INTERRUPTED 40 0.0006
544 MYOSITIS 5 0.0006
545 OROPHARYNGEAL DISCOMFORT 5 0.0006
546 LEUKOCYTOSIS 10 0.0006
547 COMPLICATION ASSOCIATED WITH DEVICE 8 0.0006
548 CONTUSION 53 0.0005
549 MUSCULOSKELETAL STIFFNESS 48 0.0005
550 HEPATITIS 14 0.0005
551 THROMBOSIS 44 0.0005
552 ADVERSE DRUG REACTION 49 0.0005
553 CHEST PAIN 101 0.0005
554 PHOTOSENSITIVITY REACTION 9 0.0005
555 STOMATITIS 33 0.0005
556 UROSEPSIS 5 0.0005
557 SOMNOLENCE 109 0.0005
558 FLUSHING 55 0.0005
559 CEREBRAL DISORDER 4 0.0005
560 ARTHROPOD BITE 4 0.0005
561 DIPLOPIA 14 0.0005
562 HEPATIC STEATOSIS 10 0.0005
563 RASH PAPULAR 12 0.0005
564 HYPERSENSITIVITY 99 0.0005
565 LACERATION 5 0.0005
566 PREMATURE BABY 16 0.0005
567 HEMIPARESIS 9 0.0005
568 ARTERIOSCLEROSIS 5 0.0005
569 HEART RATE IRREGULAR 12 0.0005
570 PAIN IN JAW 15 0.0005
571 MOVEMENT DISORDER 17 0.0005
572 CIRCULATORY COLLAPSE 9 0.0005
573 ADVERSE REACTION 7 0.0005
574 DYSPHAGIA 50 0.0005
575 INTERNAL HAEMORRHAGE 6 0.0005
576 RECALLED PRODUCT ADMINISTERED 5 0.0005
577 RASH 228 0.0005
578 DRUG EFFECT DECREASED 28 0.0005
579 LEUKOPENIA 26 0.0005
580 CONDITION AGGRAVATED 158 0.0005
581 DIFFUSE LARGE B-CELL LYMPHOMA 4 0.0005
582 CHOLELITHIASIS 17 0.0005
583 LYMPHOMA 8 0.0005
584 SINUS BRADYCARDIA 5 0.0005
585 POST PROCEDURAL HAEMORRHAGE 6 0.0005
586 NASOPHARYNGITIS 95 0.0005
587 LUNG INFECTION 8 0.0005
588 HEART RATE DECREASED 18 0.0005
589 HYPERHIDROSIS 66 0.0005
590 ASCITES 15 0.0005
591 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
592 CENTRAL NERVOUS SYSTEM LESION 7 0.0005
593 CHOLECYSTITIS 6 0.0005
594 COORDINATION ABNORMAL 7 0.0005
595 BLOOD DISORDER 4 0.0005
596 SENSORY DISTURBANCE 8 0.0005
597 HAEMATURIA 17 0.0005
598 LYMPHOPENIA 7 0.0005
599 HYPOTHERMIA 5 0.0005
600 NEURALGIA 12 0.0005
601 SINUS TACHYCARDIA 7 0.0005
602 BACK DISORDER 8 0.0005
603 SWELLING FACE 32 0.0005
604 NO ADVERSE EVENT 89 0.0005
605 MOTOR DYSFUNCTION 5 0.0005
606 BLOOD CREATININE INCREASED 32 0.0005
607 LUNG DISORDER 24 0.0005
608 PRURITUS 188 0.0005
609 NEOPLASM PROGRESSION 17 0.0005
610 CARDIOGENIC SHOCK 7 0.0005
611 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5 0.0005
612 OROPHARYNGEAL PAIN 45 0.0005
613 TEMPERATURE INTOLERANCE 5 0.0005
614 NEUROPATHY PERIPHERAL 46 0.0005
615 THERAPEUTIC RESPONSE SHORTENED 16 0.0005
616 VENTRICULAR EXTRASYSTOLES 5 0.0005
617 COUGH 135 0.0005
618 SKIN DISORDER 16 0.0005
619 ABDOMINAL DISTENSION 50 0.0005
620 GAIT INABILITY 16 0.0005
621 WEIGHT FLUCTUATION 5 0.0005
622 FATIGUE 371 0.0005
623 MUSCLE ATROPHY 6 0.0005
624 FEELING JITTERY 9 0.0005
625 ANAEMIA 90 0.0005
626 SWELLING 44 0.0005
627 EPISTAXIS 35 0.0005
628 BODY HEIGHT DECREASED 5 0.0005
629 MALAISE 205 0.0005
630 ANOREXIA 6 0.0005
631 ASTHENIA 175 0.0005
632 UNRESPONSIVE TO STIMULI 12 0.0005
633 EAR PAIN 9 0.0005
634 CARDIAC MURMUR 4 0.0005
635 ERYTHEMA 95 0.0005
636 HAEMORRHOIDS 9 0.0005
637 WHITE BLOOD CELL COUNT DECREASED 50 0.0005
638 PERIPHERAL SWELLING 71 0.0005
639 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 24 0.0005
640 DISCOMFORT 28 0.0005
641 MUCOSAL INFLAMMATION 12 0.0005
642 MUSCLE SPASMS 84 0.0005
643 MUSCULAR WEAKNESS 52 0.0005
644 SYRINGE ISSUE 8 0.0005
645 BEDRIDDEN 6 0.0005
646 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 25 0.0005
647 LOCALISED INFECTION 11 0.0005
648 GRIP STRENGTH DECREASED 4 0.0005
649 DISORIENTATION 18 0.0005
650 COLD SWEAT 8 0.0005
651 MUSCULOSKELETAL CHEST PAIN 7 0.0005
652 FEBRILE NEUTROPENIA 30 0.0005
653 ANGIOEDEMA 20 0.0005
654 LETHARGY 26 0.0005
655 PRODUCT USE IN UNAPPROVED INDICATION 112 0.0005
656 HEAD DISCOMFORT 8 0.0005
657 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
658 PREGNANCY 9 0.0004
659 CEREBRAL HAEMORRHAGE 16 0.0004
660 THROAT IRRITATION 20 0.0004
661 ANAL INCONTINENCE 4 0.0004
662 DYSPHONIA 26 0.0004
663 SINUS CONGESTION 6 0.0004
664 EYE INFECTION 5 0.0004
665 UVEITIS 6 0.0004
666 PREMATURE DELIVERY 7 0.0004
667 BONE DISORDER 8 0.0004
668 URINARY INCONTINENCE 13 0.0004
669 ABSCESS 7 0.0004
670 SCAB 5 0.0004
671 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 79 0.0004
672 CORONARY ARTERY OCCLUSION 6 0.0004
673 NEOPLASM 5 0.0004
674 NIGHT SWEATS 14 0.0004
675 GRAND MAL CONVULSION 4 0.0004
676 METASTASES TO LUNG 5 0.0004
677 PARAESTHESIA 68 0.0004
678 MENTAL STATUS CHANGES 12 0.0004
679 RHEUMATOID ARTHRITIS 49 0.0004
680 BLOOD POTASSIUM INCREASED 7 0.0004
681 GASTROINTESTINAL HAEMORRHAGE 36 0.0004
682 RASH MACULAR 15 0.0004
683 SKIN REACTION 6 0.0004
684 HEPATIC CIRRHOSIS 8 0.0004
685 CEREBROVASCULAR ACCIDENT 72 0.0004
686 RASH GENERALISED 11 0.0004
687 BLOOD SODIUM DECREASED 8 0.0004
688 EATING DISORDER 9 0.0004
689 FEELING ABNORMAL 101 0.0004
690 ATAXIA 5 0.0004
691 HYPOAESTHESIA 63 0.0004
692 SPEECH DISORDER 22 0.0004
693 JOINT STIFFNESS 11 0.0004
694 HYPERSOMNIA 12 0.0004
695 GASTRITIS 11 0.0004
696 NEUTROPHIL COUNT DECREASED 17 0.0004
697 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
698 DYSSTASIA 12 0.0004
699 HEAD INJURY 13 0.0004
700 HYPONATRAEMIA 23 0.0004
701 DECREASED IMMUNE RESPONSIVENESS 4 0.0004
702 DYSURIA 15 0.0004
703 DIARRHOEA 263 0.0004
704 DIZZINESS 202 0.0004
705 HYPERCALCAEMIA 5 0.0004
706 RASH MACULO-PAPULAR 9 0.0004
707 EYE SWELLING 15 0.0004
708 BLADDER DISORDER 4 0.0004
709 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
710 HAEMORRHAGE 42 0.0004
711 ATRIAL FIBRILLATION 39 0.0004
712 PEMPHIGUS 5 0.0004
713 CHROMATURIA 9 0.0004
714 DERMATITIS ALLERGIC 5 0.0004
715 DIVERTICULITIS 11 0.0004
716 ABDOMINAL PAIN 92 0.0004
717 EYELID PTOSIS 4 0.0004
718 SKIN DISCOLOURATION 18 0.0004
719 HYPOPHAGIA 10 0.0004
720 MYDRIASIS 5 0.0004
721 PRODUCT PREPARATION ERROR 8 0.0004
722 RHINORRHOEA 25 0.0004
723 OSTEOMYELITIS 7 0.0004
724 PAIN 237 0.0004
725 SWOLLEN TONGUE 12 0.0004
726 FOLLICULITIS 4 0.0004
727 CONSTIPATION 83 0.0004
728 GASTROINTESTINAL DISORDER 34 0.0004
729 RESPIRATORY TRACT CONGESTION 6 0.0004
730 RETCHING 8 0.0004
731 IMPAIRED WORK ABILITY 8 0.0004
732 IRRITABLE BOWEL SYNDROME 8 0.0004
733 LABORATORY TEST ABNORMAL 11 0.0004
734 GAIT DISTURBANCE 71 0.0004
735 MUSCLE TIGHTNESS 6 0.0004
736 THERAPY CESSATION 19 0.0004
737 FAECES DISCOLOURED 8 0.0004
738 INFLAMMATION 19 0.0004
739 SLEEP APNOEA SYNDROME 7 0.0004
740 LIVER INJURY 9 0.0004
741 WEIGHT INCREASED 82 0.0004
742 ASPIRATION 4 0.0004
743 ACUTE RESPIRATORY FAILURE 7 0.0004
744 GASTROINTESTINAL PAIN 4 0.0004
745 ECZEMA 19 0.0004
746 DENTAL CARIES 4 0.0004
747 FALL 120 0.0004
748 ORAL DISCOMFORT 5 0.0004
749 MATERNAL EXPOSURE DURING PREGNANCY 32 0.0004
750 ORAL HERPES 7 0.0004
751 WEIGHT DECREASED 100 0.0004
752 GLOSSODYNIA 8 0.0004
753 CARPAL TUNNEL SYNDROME 5 0.0004
754 PRODUCT USE ISSUE 67 0.0004
755 ABDOMINAL PAIN UPPER 73 0.0004
756 HOSPITALISATION 54 0.0004
757 INTERSTITIAL LUNG DISEASE 17 0.0004
758 INTENTIONAL DOSE OMISSION 10 0.0004
759 SUBDURAL HAEMATOMA 5 0.0003
760 CARDIAC FAILURE 28 0.0003
761 OFF LABEL USE 305 0.0003
762 FULL BLOOD COUNT DECREASED 7 0.0003
763 BALANCE DISORDER 30 0.0003
764 DEHYDRATION 46 0.0003
765 COLITIS 13 0.0003
766 SURGERY 20 0.0003
767 CARDIAC ARREST 28 0.0003
768 EXPOSURE DURING PREGNANCY 21 0.0003
769 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
770 PRODUCT DOSE OMISSION ISSUE 99 0.0003
771 GOUT 6 0.0003
772 BLOOD PRESSURE FLUCTUATION 8 0.0003
773 MOUTH ULCERATION 7 0.0003
774 RENAL FAILURE 44 0.0003
775 LACRIMATION INCREASED 10 0.0003
776 BLOOD COUNT ABNORMAL 5 0.0003
777 POOR QUALITY SLEEP 7 0.0003
778 SKIN CANCER 7 0.0003
779 PHARYNGEAL OEDEMA 5 0.0003
780 THYROID DISORDER 5 0.0003
781 BONE PAIN 19 0.0003
782 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
783 HAEMOPTYSIS 9 0.0003
784 THINKING ABNORMAL 6 0.0003
785 PRODUCT DISPENSING ERROR 7 0.0003
786 DISEASE PROGRESSION 38 0.0003
787 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
788 FLATULENCE 18 0.0003
789 PRODUCT USE COMPLAINT 5 0.0003
790 ABDOMINAL DISCOMFORT 53 0.0003
791 PALPITATIONS 37 0.0003
792 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
793 TOOTH DISORDER 7 0.0003
794 ULCER 5 0.0003
795 SCIATICA 5 0.0003
796 VERTIGO 19 0.0003
797 PRESCRIBED OVERDOSE 6 0.0003
798 FEELING HOT 19 0.0003
799 MYOCARDIAL INFARCTION 54 0.0003
800 SKIN ULCER 8 0.0003
801 PLASMA CELL MYELOMA 12 0.0003
802 VISION BLURRED 42 0.0003
803 DECREASED APPETITE 71 0.0003
804 OSTEONECROSIS 10 0.0003
805 EYE DISORDER 10 0.0003
806 OEDEMA PERIPHERAL 37 0.0003
807 ARTHRALGIA 126 0.0003
808 MYALGIA 51 0.0003
809 URINARY RETENTION 10 0.0003
810 NEOPLASM MALIGNANT 20 0.0003
811 CARDIAC DISORDER 28 0.0003
812 PRODUCT ADMINISTRATION ERROR 6 0.0003
813 SKIN EXFOLIATION 25 0.0003
814 SEIZURE 34 0.0003
815 DRUG TOXICITY 4 0.0003
816 DYSPNOEA EXERTIONAL 11 0.0003
817 HOT FLUSH 22 0.0003
818 PAIN IN EXTREMITY 86 0.0003
819 OSTEOPOROSIS 12 0.0003
820 NASAL CONGESTION 17 0.0003
821 PROCEDURAL PAIN 8 0.0003
822 NERVOUS SYSTEM DISORDER 9 0.0003
823 MEDICATION ERROR 16 0.0003
824 ORTHOSTATIC HYPOTENSION 5 0.0003
825 ROAD TRAFFIC ACCIDENT 12 0.0003
826 DRUG INEFFECTIVE 378 0.0003
827 APHONIA 4 0.0003
828 BURNING SENSATION 20 0.0003
829 METASTASES TO LIVER 5 0.0003
830 BLINDNESS UNILATERAL 4 0.0003
831 EYE PAIN 16 0.0003
832 LYMPHOCYTE COUNT DECREASED 5 0.0003
833 JOINT SWELLING 34 0.0003
834 METABOLIC ACIDOSIS 9 0.0003
835 GALLBLADDER DISORDER 5 0.0003
836 TOOTHACHE 5 0.0003
837 HAEMATEMESIS 7 0.0003
838 PRODUCT PRESCRIBING ISSUE 6 0.0003
839 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
840 HYPERGLYCAEMIA 10 0.0003
841 IMPAIRED HEALING 9 0.0003
842 MELAENA 6 0.0003
843 BLOOD GLUCOSE ABNORMAL 5 0.0003
844 HAEMATOMA 7 0.0003
845 AGRANULOCYTOSIS 5 0.0003
846 GENERAL PHYSICAL HEALTH DETERIORATION 31 0.0003
847 MIDDLE INSOMNIA 5 0.0003
848 SNEEZING 6 0.0003
849 MUSCULOSKELETAL PAIN 14 0.0003
850 PANCREATITIS ACUTE 6 0.0003
851 BLOOD POTASSIUM DECREASED 8 0.0003
852 PANCREATITIS 14 0.0003
853 UNEVALUABLE EVENT 20 0.0003
854 CARDIO-RESPIRATORY ARREST 11 0.0003
855 INJECTION SITE REACTION 18 0.0003
856 DRY EYE 13 0.0003
857 FEAR 7 0.0003
858 JAUNDICE 7 0.0003
859 GLAUCOMA 5 0.0003
860 AGITATION 19 0.0003
861 HYPERKALAEMIA 9 0.0003
862 BASAL CELL CARCINOMA 4 0.0003
863 FLUID RETENTION 13 0.0003
864 RESPIRATORY ARREST 7 0.0003
865 UPPER LIMB FRACTURE 5 0.0003
866 PRODUCT QUALITY ISSUE 34 0.0003
867 NERVOUSNESS 13 0.0002
868 PRODUCT PHYSICAL ISSUE 5 0.0002
869 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
870 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
871 BRADYCARDIA 13 0.0002
872 INJECTION SITE URTICARIA 6 0.0002
873 ANGINA PECTORIS 7 0.0002
874 ABASIA 6 0.0002
875 SLEEP DISORDER 17 0.0002
876 INTESTINAL OBSTRUCTION 9 0.0002
877 DIABETES MELLITUS 18 0.0002
878 COGNITIVE DISORDER 11 0.0002
879 OCULAR HYPERAEMIA 11 0.0002
880 DISEASE RECURRENCE 11 0.0002
881 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
882 DELIRIUM 8 0.0002
883 DEAFNESS 6 0.0002
884 BLOOD GLUCOSE DECREASED 11 0.0002
885 EPILEPSY 7 0.0002
886 CONFUSIONAL STATE 37 0.0002
887 PRODUCT STORAGE ERROR 20 0.0002
888 EOSINOPHILIA 4 0.0002
889 INJECTION SITE ERYTHEMA 28 0.0002
890 INJECTION SITE SWELLING 17 0.0002
891 ANXIETY 63 0.0002
892 BLINDNESS 9 0.0002
893 MOOD ALTERED 6 0.0002
894 TINNITUS 10 0.0002
895 TREATMENT FAILURE 18 0.0002
896 DEATH 185 0.0002
897 INCORRECT DOSE ADMINISTERED 49 0.0002
898 MEMORY IMPAIRMENT 29 0.0002
899 SYNCOPE 21 0.0002
900 RECTAL HAEMORRHAGE 9 0.0002
901 MULTIPLE SCLEROSIS 10 0.0002
902 HYPOGLYCAEMIA 10 0.0002
903 DISABILITY 4 0.0002
904 ABNORMAL BEHAVIOUR 8 0.0002
905 AMNESIA 13 0.0002
906 CARDIAC FAILURE CONGESTIVE 16 0.0002
907 LOWER RESPIRATORY TRACT INFECTION 9 0.0002
908 DYSKINESIA 8 0.0002
909 FEMUR FRACTURE 6 0.0002
910 WRONG TECHNIQUE IN DRUG USAGE PROCESS 7 0.0002
911 PANIC ATTACK 7 0.0002
912 POLLAKIURIA 8 0.0002
913 DERMATITIS 4 0.0002
914 WITHDRAWAL SYNDROME 8 0.0002
915 ARRHYTHMIA 9 0.0002
916 MULTIPLE SCLEROSIS RELAPSE 13 0.0002
917 DERMATITIS ATOPIC 10 0.0002
918 OSTEOARTHRITIS 8 0.0002
919 HYPOACUSIS 8 0.0002
920 FREQUENT BOWEL MOVEMENTS 5 0.0002
921 FOETAL EXPOSURE DURING PREGNANCY 15 0.0002
922 INSOMNIA 49 0.0002
923 PNEUMONITIS 5 0.0002
924 ALOPECIA 36 0.0002
925 DEMENTIA 5 0.0002
926 WOUND 5 0.0002
927 THERAPEUTIC RESPONSE UNEXPECTED 8 0.0002
928 INCORRECT DRUG ADMINISTRATION DURATION 5 0.0002
929 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
930 DRY MOUTH 14 0.0002
931 LUNG NEOPLASM MALIGNANT 7 0.0002
932 VISUAL IMPAIRMENT 21 0.0002
933 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
934 PRODUCT DOSE OMISSION 11 0.0002
935 CATARACT 10 0.0002
936 INCORRECT ROUTE OF DRUG ADMINISTRATION 6 0.0002
937 RHABDOMYOLYSIS 7 0.0002
938 DEVICE ISSUE 15 0.0002
939 IRRITABILITY 10 0.0002
940 CRYING 6 0.0002
941 TREATMENT NONCOMPLIANCE 9 0.0002
942 RESTLESSNESS 6 0.0002
943 INJECTION SITE RASH 5 0.0002
944 INJECTION SITE MASS 6 0.0002
945 VAGINAL HAEMORRHAGE 7 0.0002
946 MENTAL DISORDER 7 0.0002
947 AGEUSIA 4 0.0002
948 CARDIOVASCULAR DISORDER 4 0.0002
949 ERECTILE DYSFUNCTION 4 0.0002
950 HIP FRACTURE 5 0.0002
951 DYSPEPSIA 15 0.0002
952 ADVERSE EVENT 14 0.0002
953 BLOOD CHOLESTEROL INCREASED 7 0.0002
954 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 7 0.0001
955 ANGER 5 0.0001
956 BREAST CANCER 13 0.0001
957 PRODUCT SUBSTITUTION ISSUE 8 0.0001
958 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 28 0.0001
959 DEPRESSION 30 0.0001
960 DISTURBANCE IN ATTENTION 7 0.0001
961 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9 0.0001
962 INJECTION SITE BRUISING 10 0.0001
963 ACUTE KIDNEY INJURY 19 0.0001
964 INJECTION SITE PAIN 38 0.0001
965 HALLUCINATION 9 0.0001
966 MALIGNANT NEOPLASM PROGRESSION 12 0.0001
967 DEPRESSED MOOD 6 0.0001
968 DRUG EFFECT INCOMPLETE 4 0.0001
969 SKIN IRRITATION 5 0.0001
970 INJECTION SITE PRURITUS 7 0.0001
971 EYE IRRITATION 6 0.0001
972 INJURY 7 0.0001
973 SKIN BURNING SENSATION 7 0.0001
974 DRY SKIN 13 0.0001
975 DRUG INTERACTION 15 0.0001
976 DYSGEUSIA 7 0.0001
977 DEVICE DISLOCATION 4 0.0001
978 INTENTIONAL PRODUCT MISUSE 8 0.0001
979 DRUG WITHDRAWAL SYNDROME 8 0.0001
980 COLITIS ULCERATIVE 4 0.0001
981 DEVICE MALFUNCTION 6 0.0001
982 AGGRESSION 4 0.0001
983 SUICIDAL IDEATION 7 0.0001
984 INJECTION SITE HAEMORRHAGE 6 0.0001
985 BLOOD GLUCOSE INCREASED 13 0.0001
986 EMOTIONAL DISTRESS 8 0.0001
987 ACNE 5 0.0001
988 CHRONIC KIDNEY DISEASE 5 0.0001
989 DRUG DOSE OMISSION 10 0.0001
990 OVERDOSE 8 0.0000
991 TOXICITY TO VARIOUS AGENTS 5 0.0000